Kursprognose für BioCardia Inc (BCDA)BCDABioCardia Inc

Alphio's BCDA stock price prediction model matches the current BioCardia Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.56%). The 1-week path is $0.86 (-0.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

BioCardia Inc (BCDA) is currently a hold. The stock is trading at $0.8698, which is significantly below its 52-week high of $1.80, indicating potential upside. However, the RSI is at 31.606, suggesting the stock is oversold, but this could also indicate a continued downtrend. The forward P/E ratio is currently 0, reflecting a lack of earnings expectations, which is concerning for long-term investors. The company has reported a net loss of $2,259,000 in Q1 2026, and while there is FDA confirmation for its heart failure trial, the financials remain weak with a gross margin of 0% in recent quarters. The primary risk is the company's ongoing losses and lack of revenue generation, with a net margin of -13,700% in Q4 2024, which could hinder recovery efforts and investor confidence.

BioCardia Inc (BCDA) last closed at $0.8698, losing -2.27%. These facts feed the 1-day and 1-week BCDA price prediction above.